Cite
MLA Citation
Thomas Nyström et al.. “Novel oral glucose‐lowering drugs are associated with lower risk of all‐cause mortality, cardiovascular events and severe hypoglycaemia compared with insulin in patients with type 2 diabetes.” Diabetes, obesity & metabolism, vol. 19, no. 6, 2017, pp. 831–841. http://access.bl.uk/ark:/81055/vdc_100046457466.0x00001d